Home / Inspections / 1253298

FDA Inspection 1253298 — Abbvie Ireland NL B.V.

Abbvie Ireland NL B.V. — FEI 3004364014

The FDA completed an inspection of Abbvie Ireland NL B.V. on December 14, 2022 in Sligo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 14, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sligo (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1124019 (VAI Fri Feb 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1105474 (NAI Thu Aug 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1000859 (NAI Fri Jan 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 899864 (NAI Fri Sep 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 717041 (NAI Thu Mar 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources